Literature DB >> 1713559

Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy.

S Schwarzer1, B Eber, H Greinix, P Lind.   

Abstract

During chemotherapy with bleomycin and etoposide a 28-year-old male, suffering from germ-cell cancer, developed acute myocardial infarction. Under treatment with heparin and aspirin the patient revealed no Q-waves in ECG and recovery was without complications. Four weeks after onset of infarction, thallium-201 scintigraphy showed only a small irreversible, posteroseptal perfusion defect; coronary angiography was not performed. The chemotherapy regimen was continued and modified to etoposide as well as cisplatin and ifosfamide without recurrence of cardiac symptoms or ECG changes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713559

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

Review 1.  Cardio-oncology/onco-cardiology.

Authors:  Robert A Hong; Takeshi Iimura; Kenneth N Sumida; Robert M Eager
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

Review 2.  Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.

Authors:  Saamir A Hassan; Nicolas Palaskas; Peter Kim; Cezar Iliescu; Juan Lopez-Mattei; Elie Mouhayar; Rohit Mougdil; Kara Thompson; Jose Banchs; Syed Wamique Yusuf
Journal:  Curr Atheroscler Rep       Date:  2018-02-08       Impact factor: 5.113

Review 3.  Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.

Authors:  Nicole S Klee; Cameron G McCarthy; Patricia Martinez-Quinones; R Clinton Webb
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-09-15

Review 4.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

Review 5.  Myocardial infarction in young patients with Hodgkin's disease--potential pathogenic role of radiotherapy, chemotherapy, and splenectomy.

Authors:  K H Scholz; C Herrmann; U Tebbe; J M Chemnitius; U Helmchen; H Kreuzer
Journal:  Clin Investig       Date:  1993-01

Review 6.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

7.  Bleomycin cardiotoxicity during chemotherapy for an ovarian germ cell tumor.

Authors:  M Didagelos; A Boutis; N Diamantopoulos; M Sotiriadou; C Fotiou
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

8.  The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.

Authors:  A-C Piketty; A Fléchon; A Laplanche; E Nouyrigat; J-P Droz; C Théodore; K Fizazi
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

9.  Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.

Authors:  Aleksander Skardal; Sean V Murphy; Mahesh Devarasetty; Ivy Mead; Hyun-Wook Kang; Young-Joon Seol; Yu Shrike Zhang; Su-Ryon Shin; Liang Zhao; Julio Aleman; Adam R Hall; Thomas D Shupe; Andre Kleensang; Mehmet R Dokmeci; Sang Jin Lee; John D Jackson; James J Yoo; Thomas Hartung; Ali Khademhosseini; Shay Soker; Colin E Bishop; Anthony Atala
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

10.  Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.

Authors:  Harshal Nemade; Umesh Chaudhari; Aviseka Acharya; Jürgen Hescheler; Jan Georg Hengstler; Symeon Papadopoulos; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2018-02-03       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.